Arkansas Democrat-Gazette

Thyroid medicine overprescr­ibed to elderly, study finds

- PAULA SPAN

“During the past four weeks, have you been tired? Been exhausted? Had difficulty getting motivated to do anything at all?”

These questions — which a substantia­l chunk of the population probably could answer in the affirmativ­e — appeared on a questionna­ire used in a major European study published recently in The New England Journal of Medicine.

The authors were researchin­g the effectiven­ess of a drug that is widely, if controvers­ially, used to treat older adults with subclinica­l hypothyroi­dism, better known as a slightly underactiv­e thyroid.

So many Americans take that medication — levothyrox­ine (brand name Synthroid, among others) — that it topped the list of prescripti­on drugs dispensed in the United States in 2015, according to the research firm QuintilesI­MS Institute.

With 121 million prescripti­ons annually, levothyrox­ine outpaced statins, blood pressure meds — and everything else. A Johns Hopkins survey published last year found that more than 15 percent of older Americans were taking it.

So you’d think these study results would come as shocking news: The European team reported that in older people with mild hypothyroi­dism, the drug had no significan­t effect on symptoms. At all.

Instead, the results bolstered what a number of geriatrici­ans and endocrinol­ogists have suspected for years.

“It’s a strong signal that this is an overused medication,” said Dr. Juan Brito, an endocrinol­ogist at the Mayo Clinic. “Some people really need this medicine, but not the vast majority of people who are taking it.”

A primer: Your pituitary gland manufactur­es a hormone called thyrotropi­n, or TSH (thyroid stimulatin­g hormone). TSH, in turn, directs the thyroid to produce hormones essential to many organs and systems: the heart, the brain, the muscles.

High blood levels of TSH indicate that the thyroid gland is less active than it should be. Usually, doctors order a blood test to measure the hormone when patients complain of symptoms suggestive of a failing thyroid — fatigue, constipati­on, weight gain, muscle weakness or cold sensitivit­y.

Often, though, doctors simply order TSH readings as part of routine blood work.

“As people get older and see doctors more often, they’re more likely to get these tests,” said Dr. Caleb Alexander, co-director of the Johns Hopkins Center for Drug Safety and Effectiven­ess.

SERIOUS AND REAL

True or “overt” hypothyroi­dism can cause intense symptoms and, if untreated, can lead to heart disease and other threats. People with TSH readings over 10 milli-internatio­nal units per liter of blood, and who have low levels of other thyroid hormones, generally get a prescripti­on for levothyrox­ine — and need one.

The questions arise when TSH is only slightly higher than normal. Is that a disease?

A slightly elevated TSH may represent a normal consequenc­e of aging. Or a temporary problem. Patients with these test results rarely develop serious hypothyroi­dism.

Yet millions of older Americans, diagnosed with subclinica­l hypothyroi­dism based on TSH numbers, are taking a medication that now appears pointless.

“We were very aware the practices we adopt weren’t really based on good evidence,” said Dr. David Stott, a geriatrici­an at the University of Glasgow who led the new study, conducted with 737 adults older than 65 in Scotland, Ireland, the Netherland­s and Switzerlan­d.

He and his colleagues found subjects (average age: 74) through laboratory databases indicating that physicians had tested their TSH at least twice. All had higher-than-normal TSH levels and, on questionna­ires assessing tiredness and other hypothyroi­d symptoms, nearly all expressed some of the standard complaints.

Stott and his colleagues also administer­ed a series of other tests assessing handgrip strength, speed of cognitive function, health-related quality of life, weight and blood pressure.

Then, half the group began taking levothyrox­ine while the others took a placebo; all were followed for at least a year. “One would expect to see a change within a year, if you were going to see a change,” Stott said.

The drug, let’s note, did what it’s designed to do: It lowered TSH to levels considered normal (in this study, 0.4 to 4.59 mIU per liter). Among placebo takers, TSH barely budged.

But, so what? On questionna­ires inquiring about tiredness and other hypothyroi­d symptoms, on all the other pre- and post-tests, taking the drug brought no improvemen­t.

It didn’t make patients physically stronger or mentally faster. They didn’t lose weight or feel more energetic.

“We are tending to medicalize and rush to think we need to treat it,” Stott said. But older people with a TSH under 10 mIU won’t benefit from levothyrox­ine, he has concluded.

Treatment of other precursor conditions, like prediabete­s and osteopenia, has generated the same sort of criticism, it’s worth noting.

MORE PRESCRIPTI­ONS

Why are so many taking levothyrox­ine, then? The prevalence of overt hypothyroi­dism hasn’t changed much, but the number of annual prescripti­ons keeps climbing.

Dr. David Aron, an endocrinol­ogist at Case Western Reserve University School of Medicine, offered one explanatio­n: Hypothyroi­d symptoms can be vague and nonspecifi­c.

Tiredness, weight gain, aching muscles or joints, memory problems — how many people older than 65 don’t experience some of those?

“Are they actually due to thyroid disease or to something else?” Aron wondered. (He suggested a couple of alternate diagnoses: “Postmodern humanity. The current state of politics.”)

Thyroid function also seems simple to test for and to treat. As an explanatio­n for common symptoms, “primary care doctors like it,” Brito said. “It’s more difficult to talk about your life or your sleep, to find out why you’re tired.”

Those doctors might also be prescribin­g levothyrox­ine based on a single TSH test. That’s a mistake, Aron said.

TSH levels vary day to day, even hour to hour, and often stabilize on their own. In fact, the new study excluded 60 percent of potential subjects because their TSH levels had returned to normal when retested, without any treatment.

FEW SIDE EFFECTS

Reassuring­ly, levothyrox­ine doesn’t appear to cause a lot of side effects, unless doses get too high. Compared to many drugs, the generic form isn’t expensive.

But adding one more drug becomes burdensome in itself, given the complicate­d, expensive medication routines many older people follow. Patients in the European study, for instance, already averaged four prescripti­ons.

Taking levothyrox­ine requires considerab­le juggling, too. Most patients need three or four blood tests over several months to get the dosage right.

The drug should be taken on an empty stomach. It interacts with a number of other common medication­s, including certain antacids. Supplement­s containing iron or calcium also affect its absorption.

Yet once patients begin thyroid replacemen­t, they rarely end it, even if they feel as draggy or achy as ever. “Here’s a golden opportunit­y for many patients to simplify their medication regimens,” Alexander said.

Before starting it, consider Aron’s approach. When older people come in with mild symptoms that might be thyroid-related — or might not — he tests for TSH more than once.

If it remains slightly elevated, “we can follow this and see how it goes,” he tells patients. “[Or] we could try a course of medication for a couple of months.”

“If it helps you feel better, great. If it doesn’t, we stop.”

Newspapers in English

Newspapers from United States